fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Advertisment

Timing of COVID-19 shot can change menstrual cycle length

Written by | 4 Mar 2024 | COVID-19

Oregon Health & Science University researchers have confirmed that the timing of COVID-19 vaccination is associated with slight, temporary changes in menstrual cycle length.

The study, published today in the journal Obstetrics & Gynecology, found that individuals receiving a COVID-19 vaccine during the first half of their menstrual cycle are more likely to experience cycle length changes than those receiving a vaccine in the second half.

Building on prior work from the same research team that first identified an association between COVID-19 vaccines and menstrual cycle length, this study furthers understanding of how timing of vaccination is associated with this change.

“Understanding these changes on a population level allows us to more effectively counsel patients about what to expect with a COVID-19 vaccine,” said Alison Edelman, M.D., M.P.H., the study’s lead author and professor of obstetrics and gynecology and division director of Complex Family Planning in the OHSU School of Medicine. “We hope this work helps validate the public’s experiences and ease fears and anxiety around vaccination.”

With data from nearly 20,000 users of the FDA-cleared birth control application Natural Cycles, researchers sought to determine whether timing of COVID-19 vaccination is associated with changes in menstrual cycle length. Individuals in the cohort analysis granted researchers permission to use their de-identified data.

Researchers compared three groups: individuals vaccinated in the follicular phase, the first phase of the menstrual cycle when the body collects follicles, or small sacs that have the potential to release an egg for fertilization during ovulation; individuals vaccinated in the luteal phase, the second part of the menstrual cycle starting after ovulation; and an unvaccinated control group.

Analysis shows that individuals who were vaccinated in the follicular phase experienced, on average, a one-day increase in cycle length when compared with their pre-vaccination cycle average. Changes typically resolved in the cycle after vaccination.

While there is now a large body of evidence demonstrating that the COVID-19 vaccine is associated with temporary menstrual cycle disturbances, the exact biological mechanism for these changes is still unknown.

“We are constantly learning about how our bodies work together, but we do know the immune and reproductive systems interact closely with one another,” Edelman explained. “Based on this relationship, it is certainly plausible that individuals may see temporary changes in their menstrual cycle due to the immune response that vaccines are designed to produce.”

Experiencing an unexpected change in menstrual cycles can be alarming. Researchers emphasize that these findings shouldn’t be a cause for concern, but should provide reassurance that, if changes in cycle length occur with vaccination, they are likely to be small and temporary. Individuals who notice prolonged changes in menstruation are encouraged to seek guidance from their clinician.

Since the study’s data were gathered from individuals with regular menstrual cycles pre-vaccine, the team emphasizes that additional research is needed to establish whether observed differences vary in some people who experience irregularities in their cycle. Additionally, researchers hope to better understand how other aspects of the menstrual cycle are affected by vaccination, such as menstrual-related symptoms and menstrual flow.

“Historically, menstruation has not been prioritized in scientific and medical research, which leaves individuals who menstruate with a lot of unanswered questions, especially when they are experiencing something that’s not ‘normal’ for their body,” Edelman said. “Menstruation is a key indicator of fertility and overall health, so understanding these changes is very important to us as reproductive health researchers and to our patients.”

Research reported in this publication was funded by the National Institutes of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development and Office of Research on Women’s Health under award number HD089957. The work is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.